770790888	770790888	CD	B-NP	O
|	|	NN	I-NP	O
VDMH	VDMH	NN	I-NP	O
|	|	NN	I-NP	O
17949119	17949119	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9471365	9471365	CD	B-NP	O
|	|	CC	I-NP	O
3/2/2007	3/2/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
PREGNANCY	PREGNANCY	NN	I-NP	O
,	,	,	O	O
6	6	CD	B-NP	O
WEEKS	WEEKS	NNP	I-NP	O
DIABETIC	DIABETIC	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/27/2007	1/27/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/27/2007	5/27/2007	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
OBEY	OBEY	NNP	B-NP	O
,	,	,	O	O
LAWRENCE	LAWRENCE	NNP	B-NP	O
MD	MD	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Obstetrics/Maternal	Obstetrics/Maternal	NNP	B-NP	O
Fetal	Fetal	NNP	I-NP	O
Medicine	Medicine	NNP	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Pre-gestational	Pre-gestational	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Recurrent	Recurrent	JJ	B-NP	O
SABs	SAB	NNS	I-NP	O
4	4	CD	B-NP	O
.	.	.	O	O

Hepatitis	Hepatitis	NNP	B-NP	O
B.	B.	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
36-year-old	36-year-old	JJ	I-NP	O
G16	G16	NN	I-NP	O
,	,	,	O	O
P0-0-15-0	P0-0-15-0	NN	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
at	at	IN	B-PP	O
6	6	CD	B-NP	O
and	and	CC	I-NP	O
4/7	4/7	CD	I-NP	O
weeks	week	NNS	I-NP	O
by	by	IN	B-PP	O
LMP	LMP	NN	B-NP	B-protein
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
ultrasound	ultrasound	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
transfer	transfer	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
High-Risk	High-Risk	NNP	I-NP	O
Obstetric	Obstetric	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
,	,	,	O	O
admitted	admit	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Fuller	Fuller	NNP	I-NP	O
Antepartum	Antepartum	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
diabetic	diabetic	JJ	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
presented	present	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Special	Special	NNP	I-NP	O
OB	OB	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
patient	patient	NN	I-NP	O
for	for	IN	B-PP	O
prenatal	prenatal	JJ	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

Review	Review	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
recent	recent	JJ	I-NP	O
glucose	glucose	NN	I-NP	O
control	control	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
suboptimal	suboptimal	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
view	view	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
view	view	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
other	other	JJ	I-NP	O
issues	issue	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
diabetic	diabetic	JJ	B-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
adjustment	adjustment	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	I-NP	O
evaluation	evaluation	NN	I-NP	O
regarding	regard	VBG	B-VP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
present	present	JJ	B-NP	O
pregnancy	pregnancy	NN	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
last	last	JJ	I-NP	O
menstrual	menstrual	JJ	I-NP	O
period	period	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
.	.	.	O	O

Ultrasound	Ultrasound	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
9/5/07	9/5/07	CD	B-NP	O
,	,	,	O	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
6.6-week	6.6-week	JJ	I-NP	O
intrauterine	intrauterine	JJ	I-NP	O
pregnancy	pregnancy	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
fetal	fetal	JJ	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
110	110	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
estimated	estimate	VBN	I-NP	O
date	date	NN	I-NP	O
of	of	IN	B-PP	O
confinement	confinement	NN	B-NP	O
is	be	VBZ	B-VP	O
4/19/07	4/19/07	CD	B-NP	O
.	.	.	O	O

Prenatal	Prenatal	JJ	B-NP	O
screening	screening	NN	I-NP	O
labs	lab	NNS	I-NP	O
were	be	VBD	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
blood	blood	NN	B-NP	O
group	group	NN	I-NP	O
O	O	NN	I-NP	O
+	+	SYM	B-NP	O
ve	ve	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
ST	ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
2000	2000	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
infarct	infarct	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
presumed	presumed	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descending	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
complete	complete	JJ	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mid-to-distal	mid-to-distal	JJ	I-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
thrombosis	thrombosis	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
TPA	TPA	NN	B-NP	O
and	and	CC	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2000	2000	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
last	last	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
2002	2002	CD	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
never	never	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
echo	echo	NN	I-NP	O
since	since	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
climb	climb	VB	I-VP	O
four	four	CD	B-NP	O
flights	flight	NNS	I-NP	O
of	of	IN	B-PP	O
stairs	stair	NNS	B-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
apartment	apartment	NN	I-NP	O
,	,	,	O	O
haveing	have	VBG	B-VP	O
to	to	TO	I-VP	O
pause	pause	VB	I-VP	O
after	after	IN	B-PP	O
two	two	CD	B-NP	O
flights	flight	NNS	I-NP	O
of	of	IN	B-PP	O
stairs	stair	NNS	B-NP	O
to	to	TO	B-VP	O
catch	catch	VB	I-VP	O
her	her	PRP$	B-NP	O
breath	breath	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
diagnosed	diagnose	VBN	B-VP	O
in	in	IN	B-PP	O
2000	2000	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
medical	medical	JJ	I-NP	O
admission	admission	NN	I-NP	O
in	in	IN	B-PP	O
2006	2006	CD	B-NP	O
for	for	IN	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
incidentally	incidentally	RB	B-ADVP	O
injected	inject	VBD	B-VP	O
Humalog	Humalog	NNP	B-NP	O
instead	instead	RB	B-PP	O
of	of	IN	I-PP	O
Lantus	Lantus	NNP	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Humalog	Humalog	NNP	I-NP	B-DNA
7	7	CD	I-NP	I-DNA
units	unit	NNS	I-NP	I-DNA
b.i.d.	b.i.d.	RB	B-ADVP	O
and	and	CC	O	O
Lantus	Lantus	NNP	B-NP	O
12	12	CD	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
fasting	fast	VBG	I-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
150s	150	NNS	I-NP	O
before	before	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
measurements	measurement	NNS	I-NP	O
were	be	VBD	B-VP	O
over	over	IN	B-PP	O
200	200	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
fasting	fasting	NN	I-NP	O
sugar	sugar	NN	I-NP	O
was	be	VBD	B-VP	O
123	123	CD	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
,	,	,	O	O
diagnosed	diagnose	VBN	B-VP	O
in	in	IN	B-PP	O
2005	2005	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	B-protein
E	E	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
in	in	IN	B-PP	O
2005	2005	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
previously	previously	RB	I-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
Epivir	Epivir	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
current	current	JJ	I-NP	O
pregnancy	pregnancy	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
OB/GYN	OB/GYN	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
fibroid	fibroid	JJ	I-NP	O
uterus	uterus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
miscarriages	miscarriage	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fibroid	fibroid	JJ	I-NP	O
uterus	uterus	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
report	report	NN	B-NP	O
pelvic	pelvic	JJ	I-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
setting	setting	NN	I-NP	O
.	.	.	O	O

Ultrasound	Ultrasound	NN	B-NP	O
had	have	VBD	B-VP	O
shown	show	VBN	I-VP	O
an	an	DT	B-NP	O
8-10	8-10	CD	I-NP	O
cm	cm	NN	I-NP	O
dominant	dominant	JJ	I-NP	O
posterior	posterior	JJ	I-NP	O
fibroid	fibroid	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
occasionally	occasionally	RB	B-ADVP	O
takes	take	VBZ	B-VP	O
oxycodone	oxycodone	NN	B-NP	O
for	for	IN	B-PP	O
fibroid	fibroid	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
recurrent	recurrent	JJ	I-NP	O
miscarriages	miscarriage	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
fifteen	fifteen	CD	B-NP	O
SABs	SAB	NNS	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
with	with	IN	B-PP	O
over	over	IN	B-NP	O
10	10	CD	I-NP	O
dilatation	dilatation	NN	I-NP	O
and	and	CC	I-NP	O
evacuations	evacuation	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
one	one	CD	B-NP	O
molar	molar	JJ	I-NP	O
pregnancy	pregnancy	NN	I-NP	O
with	with	IN	B-PP	O
subsequent	subsequent	JJ	B-NP	O
choriocarcinoma	choriocarcinoma	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
losses	loss	NNS	I-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
trimester	trimester	NN	I-NP	O
,	,	,	O	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
12	12	CD	I-NP	O
weeks	week	NNS	I-NP	O
'	'	POS	B-NP	O
gestation	gestation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
evaluated	evaluate	VBN	I-VP	O
previously	previously	RB	B-ADVP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
thrombophilia	thrombophilia	NN	I-NP	B-protein
workup	workup	NN	I-NP	I-protein
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
negative	negative	JJ	B-NP	O
multiple	multiple	JJ	I-NP	O
times	time	NNS	I-NP	O
aside	aside	RB	B-ADVP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
MTHFR	MTHFR	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
mutation	mutation	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
whether	whether	IN	B-SBAR	O
this	this	DT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
addressed	address	VBN	I-VP	O
previously	previously	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
previously	previously	RB	I-VP	O
been	be	VBN	I-VP	O
told	tell	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
reproductive	reproductive	JJ	I-NP	O
endocrinologist	endocrinologist	NN	I-NP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
consider	consider	VB	I-VP	O
adoption	adoption	NN	B-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
gestational	gestational	JJ	I-NP	O
carrier	carrier	NN	I-NP	O
.	.	.	O	O

Chromosomes	Chromosome	NNS	B-NP	B-DNA
on	on	IN	B-PP	O
several	several	JJ	B-NP	O
pathology	pathology	NN	I-NP	O
specimens	specimen	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
abortions	abortion	NNS	I-NP	O
showed	show	VBD	B-VP	O
aneuploidy	aneuploidy	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
currently	currently	RB	B-ADVP	O
denies	deny	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
sexually	sexually	RB	B-NP	O
transmitted	transmit	VBN	I-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
dysplasia	dysplasia	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CIN	CIN	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
and	and	CC	O	O
CIN	CIN	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
in	in	IN	B-PP	O
1990	1990	CD	B-NP	O
and	and	CC	I-NP	O
1992	1992	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
LEEP	LEEP	NN	I-NP	B-protein
in	in	IN	B-PP	O
1992	1992	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
HSIL	HSIL	NN	B-NP	B-protein
.	.	.	O	O

All	All	DT	B-NP	O
subsequent	subsequent	JJ	I-NP	O
Pap	Pap	NN	I-NP	O
smears	smear	NNS	I-NP	O
were	be	VBD	B-VP	O
either	either	CC	O	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Last	Last	JJ	B-NP	O
Pap	Pap	NN	I-NP	O
smear	smear	NN	I-NP	O
done	do	VBN	B-VP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
2006	2006	CD	I-NP	O
at	at	IN	B-PP	O
Rexmo	Rexmo	NNP	B-NP	O
Sha	Sha	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Of	Of	NNP	I-NP	O
was	be	VBD	B-VP	O
insufficient	insufficient	JJ	B-ADJP	O
for	for	IN	B-PP	O
analysis	analysis	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
choriocarcinoma	choriocarcinoma	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
molar	molar	JJ	I-NP	O
pregnancy	pregnancy	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
then	then	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
into	into	IN	B-PP	O
a	a	DT	B-NP	O
subsequent	subsequent	JJ	I-NP	O
choriocarcinoma	choriocarcinoma	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
methotrexate	methotrexate	NN	B-NP	O
,	,	,	O	O
actinomycin	actinomycin	NN	B-NP	O
D	D	NN	I-NP	O
and	and	CC	I-NP	O
Cytoxan	Cytoxan	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
VP-16	VP-16	NN	B-NP	B-protein
,	,	,	I-NP	O
cisplatin	cisplatin	NN	I-NP	O
and	and	CC	I-NP	O
bleomycin	bleomycin	NN	I-NP	O
with	with	IN	B-PP	O
presumed	presume	VBN	B-NP	O
cure	cure	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Dilatation	Dilatation	NN	B-NP	O
and	and	CC	I-NP	O
evacuation	evacuation	NN	I-NP	O
x10	x10	NN	I-NP	O
,	,	,	O	O
hysteroscopy	hysteroscopy	NN	B-NP	O
for	for	IN	B-PP	O
infertility	infertility	NN	B-NP	O
workup	workup	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
LEEP	LEEP	NN	B-NP	B-protein
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Humalog	Humalog	JJ	B-NP	B-DNA
Insulin	Insulin	NN	I-NP	I-DNA
7	7	CD	B-NP	I-DNA
units	unit	NNS	I-NP	I-DNA
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
12	12	CD	I-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
stopped	stop	VBD	B-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
pregnancy	pregnancy	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
lamivudine/Epivir	lamivudine/Epivir	NN	B-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
150	150	CD	B-NP	O
daily	daily	RB	B-ADVP	O
stopped	stop	VBD	B-VP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
current	current	JJ	B-NP	O
pregnancy	pregnancy	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Former	Former	JJ	B-NP	O
smoker	smoker	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-VP	O
up	up	RP	B-PRT	O
smoking	smoking	NN	B-NP	O
in	in	IN	B-PP	O
2000	2000	CD	B-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarct	infarct	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
abuse	abuse	NN	I-NP	O
or	or	CC	O	O
IV	IV	CD	B-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	life	NNS	I-NP	O
in	in	IN	B-PP	O
Doreska	Doreska	NNP	B-NP	O
Dr	Dr	NNP	I-NP	O
,	,	,	O	O
Nah	Nah	NNP	B-NP	O
Min	Min	NNP	I-NP	O
Knox	Knox	NNP	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
boyfriend	boyfriend	NN	I-NP	O
,	,	,	O	O
unemployed	unemployed	JJ	B-ADJP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
GYN	GYN	NN	B-NP	O
malignancies	malignancy	NNS	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
maternal	maternal	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
longstanding	longstanding	JJ	B-ADJP	O
.	.	.	O	O

Father	Father	RB	B-ADVP	O
with	with	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
50s	50	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
diabetic	diabetic	JJ	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
reported	report	VBN	I-VP	O
poor	poor	JJ	B-NP	O
diabetic	diabetic	JJ	I-NP	O
control	control	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
additional	additional	JJ	I-NP	O
insulin	insulin	NN	I-NP	O
needs	need	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Lantus	Lantus	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
at	at	IN	B-PP	O
nighttime	nighttime	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
using	use	VBG	I-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	O
lispro	lispro	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
lispro	lispro	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
fingerstick	fingerstick	NN	I-NP	O
glucose	glucose	NN	I-NP	O
control	control	NN	I-NP	O
improved	improve	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
fasting	fast	VBG	I-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
90	90	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
from	from	IN	B-PP	O
93	93	CD	B-NP	O
to	to	TO	B-PP	O
139	139	CD	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
HbA1c	HbA1c	NN	I-NP	B-protein
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
6.7	6.7	CD	B-NP	O
,	,	,	O	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
Nutrition	Nutrition	NN	I-NP	O
consult	consult	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
High-Risk	High-Risk	NNP	I-NP	O
Obstetric	Obstetric	NNP	I-NP	O
and	and	CC	O	O
Diabetic	Diabetic	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Borguez	Borguez	NNP	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Cardiology	Cardiology	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
aspirin	aspirin	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarct	infarct	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
early	early	JJ	I-NP	O
age	age	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
after	after	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
presumed	presume	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
longstanding	longstanding	NN	I-NP	O
.	.	.	O	O

Cardiology	Cardiology	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
impression	impression	NN	I-NP	O
was	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
thrombosis	thrombosis	NN	I-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypokinesia	hypokinesia	NN	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
infarct	infarct	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
hypercoagulable	hypercoagulable	JJ	I-NP	O
state	state	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
their	their	PRP$	B-NP	O
recommendation	recommendation	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	I-VP	O
start	start	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
pregnancy	pregnancy	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
adjusted	adjust	VBD	B-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
90	90	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
transition	transition	NN	I-NP	O
to	to	TO	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
postpartum	postpartum	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
likely	likely	RB	B-ADJP	O
long-term	long-term	JJ	I-ADJP	O
,	,	,	O	O
possibly	possibly	RB	B-ADVP	O
lifelong	lifelong	VB	B-VP	O
duration	duration	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Consult	Consult	NNP	I-NP	O
Team	Team	NNP	I-NP	O
noted	note	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
MTHFR	MTHFR	NN	I-NP	B-protein
mutation	mutation	NN	I-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
resulted	result	VBN	I-VP	O
in	in	IN	B-PP	O
elevated	elevate	VBN	B-NP	O
homocysteine	homocysteine	NN	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
they	they	PRP	B-NP	O
did	do	VBD	B-VP	O
agree	agree	VB	I-VP	O
that	that	IN	B-SBAR	O
folate	folate	JJ	B-NP	O
supplementation	supplementation	NN	I-NP	O
at	at	IN	B-PP	O
high	high	JJ	B-NP	O
doses	dose	NNS	I-NP	O
was	be	VBD	B-VP	O
indicated	indicate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
90	90	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
subcutaneously	subcutaneously	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
Cardiology	Cardiology	NNP	B-NP	O
followup	followup	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Jasper	Jasper	NNP	I-NP	O
Erps	Erps	NNP	I-NP	O
on	on	IN	B-PP	O
3/6/07	3/6/07	CD	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
,	,	,	O	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
palpitations	palpitation	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hepatitis	Hepatitis	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
liver	liver	NN	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
panel	panel	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
disease	disease	NN	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
in	in	IN	B-PP	O
2005	2005	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	B-protein
hepatitis	hepatitis	NN	I-NP	I-protein
E	E	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
Epivir	Epivir	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
stopped	stop	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
current	current	JJ	I-NP	O
pregnancy	pregnancy	NN	I-NP	O
.	.	.	O	O

Liver	Liver	NN	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
serologies	serology	NNS	B-NP	O
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
hepatitis	hepatitis	NN	I-NP	B-protein
E	E	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
E	E	NN	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Hepatitis	Hepatitis	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
surface	surface	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
and	and	CC	O	O
hepatitis	hepatitis	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
core	core	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
were	be	VBD	B-VP	O
reactive	reactive	JJ	B-ADJP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
B	B	NN	I-NP	O
viral	viral	JJ	I-NP	O
load	load	NN	I-NP	O
was	be	VBD	B-VP	O
pending	pende	VBG	B-ADJP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
,	,	,	O	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
appointment	appointment	NN	I-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
arranged	arrange	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Lavy	Lavy	NNP	I-NP	O
,	,	,	O	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Division	Division	NNP	I-NP	O
of	of	IN	B-PP	O
Gastroenterology	Gastroenterology	NNP	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Sasspan	Sasspan	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
any	any	DT	B-NP	O
lamivudine	lamivudine	NN	I-NP	O
until	until	IN	B-SBAR	O
Gastroenterology	Gastroenterology	NNP	B-NP	O
followup	followup	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
GI	GI	NN	I-NP	O
complaints	complaint	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
having	have	VBG	B-VP	O
normal	normal	JJ	B-NP	O
regular	regular	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

history	history	NN	B-NP	O
of	of	IN	B-PP	O
fibroids	fibroid	NNS	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
again	again	RB	B-ADVP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
8-cm	8-cm	JJ	I-NP	O
fibroid	fibroid	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
ultrasound	ultrasound	JJ	I-NP	O
scan	scan	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
required	require	VBD	B-VP	O
rare	rare	JJ	B-NP	O
intermittent	intermittent	JJ	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
as	as	IN	B-SBAR	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
presumed	presume	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
fibroid	fibroid	JJ	I-NP	O
uterus	uterus	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Prenatal	Prenatal	JJ	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
her	her	PRP$	B-NP	O
first	first	JJ	I-NP	O
trimester	trimester	NN	I-NP	O
labs	lab	NNS	I-NP	O
sent	send	VBN	B-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

GC	GC	NN	B-NP	O
and	and	CC	I-NP	O
chlamydia	chlamydia	NN	I-NP	O
testing	testing	NN	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	B-cell_line
culture	culture	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
O	O	NN	B-NP	O
+	+	SYM	B-NP	O
ve	ve	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
MTHFR	MTHFR	NN	B-NP	B-protein
mutation	mutation	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
recurrent	recurrent	JJ	I-NP	O
SABs	SAB	NNS	I-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
prenatal	prenatal	JJ	B-NP	O
vitamins	vitamin	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
high-dose	high-dose	JJ	B-NP	O
folic	folic	JJ	I-NP	O
acid	acid	NN	I-NP	O
,	,	,	I-NP	O
B12	B12	NN	I-NP	B-protein
and	and	CC	I-NP	O
B6	B6	NN	I-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
view	view	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
diabetic	diabetic	JJ	I-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
transiently	transiently	RB	I-NP	O
elevated	elevated	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
to	to	TO	B-PP	O
1.2	1.2	CD	B-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
went	go	VBD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
0.7	0.7	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
24-hour	24-hour	JJ	I-NP	O
urine	urine	NN	I-NP	O
collection	collection	NN	I-NP	O
sent	send	VBD	B-VP	O
,	,	,	O	O
this	this	DT	B-NP	O
returned	return	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
at	at	IN	B-PP	O
92	92	CD	B-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
Ophthalmology	Ophthalmology	NN	I-NP	O
retinal	retinal	JJ	I-NP	O
exam	exam	NN	I-NP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
health	health	NN	I-NP	O
center	center	NN	I-NP	O
this	this	DT	B-NP	O
year	year	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
pregnancy	pregnancy	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
require	require	VB	I-VP	O
ultrasounds	ultrasound	NNS	B-NP	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
and	and	CC	I-NP	O
17	17	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
fetal	fetal	JJ	I-NP	O
echo	echo	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
recommended	recommend	VBN	I-NP	O
testing	testing	NN	I-NP	O
for	for	IN	B-PP	O
pre-gestational	pre-gestational	JJ	B-NP	O
diabetics	diabetic	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pregnancy	pregnancy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
condition	condition	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
followup	followup	NN	B-NP	O
appointments	appointment	NNS	I-NP	O
arranged	arrange	VBN	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
various	various	JJ	I-NP	O
specialties	specialty	NNS	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
without	without	IN	B-PP	O
services	service	NNS	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Lovenox	Lovenox	VBG	B-VP	O
subcutaneously	subcutaneously	RB	B-NP	O
90	90	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Vitamin	Vitamin	NN	B-NP	O
B12	B12	NN	I-NP	O
100	100	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Folate	Folate	NN	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Prenatal	Prenatal	JJ	B-NP	O
vitamins	vitamin	NNS	I-NP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
20	20	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
q.p.m.	q.p.m.	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
lispro	lispro	NN	I-NP	I-protein
8	8	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-NP	O
AC	AC	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
lispro	lispro	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
a	a	DT	B-NP	O
AC	AC	NN	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	JJ	B-NP	O
APPOINTMENTS	APPOINTMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Special	Special	JJ	B-NP	O
OB	OB	NN	I-NP	O
on	on	IN	B-PP	O
1/5/07	1/5/07	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Lantry	Lantry	NNP	I-NP	O
,	,	,	O	O
Endocrinology	Endocrinology	NNP	B-NP	O
on	on	IN	B-PP	O
1/5/07	1/5/07	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Nolan	Nolan	NNP	I-NP	O
Conners	Conners	NNP	I-NP	O
,	,	,	O	O
Cardiology	Cardiology	NNP	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
3/6/07	3/6/07	CD	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Winscott	Winscott	NNP	I-NP	O
,	,	,	O	O
Gastroenterology	Gastroenterology	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
receive	receive	VB	I-VP	O
letter	letter	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
appointment	appointment	NN	I-NP	O
from	from	IN	B-PP	O
GI	GI	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-2728371	2-2728371	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MAIOCCO	MAIOCCO	NNP	B-NP	O
,	,	,	O	O
DALLAS	DALLAS	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MARCOLINA	MARCOLINA	NNP	B-NP	O
,	,	,	O	O
EMMITT	EMMITT	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9930654	9930654	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
7/28/07	7/28/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/28/07	7/28/07	CD	B-NP	O

